Top 5 reasons to join us at the ASHG 2021 virtual conference
What’s happening at the ASHG 2021 virtual conference?
The ASHG 2021 virtual conference is almost here and we have an exciting, action-packed agenda in store for you. Here are the top 5 sessions you should add to your calendar:
1. Late-breaking educational session
October 19 at 12:30 p.m. EDT: Altered microRNA expression in COVID-19 patients accurately identifies SARS-CoV-2 infection
- Speaker: Ryan Farr, Ph.D. Host Response Team, Health and Biosecurity (H&B) at the Australian Centre for Disease Preparedness (ACDP), CSIRO, Australia
What it’s about: By examining the host response to SARS-CoV-2 infection, we can achieve valuable insights into viral pathogenesis and COVID-19 progression. This study demonstrates that SARS-CoV-2 infection results in a significant host miRNA response that aligns with our current knowledge of COVID-19 induced inflammation. By using a multivariate machine learning approach, researchers have developed a robust miRNA biomarker signature of COVID-19. This signature could complement existing diagnostic tests by providing a new approach to detecting cases that might otherwise be missed.
2. Live, interactive co-lab sessions
- Speaker: Zhijie Yang and Youxiang Wang, Atila BioSystems, Inc, USA
What it’s about: A digital PCR-based NIPT assay offers the simplest workflow (no library preparation needed), the fastest turnaround time (about 3 hours) and the most affordable cost. We report the first 5-color NIPT assay on the QIAcuity platform in a single reaction to simultaneously quantify chromosomes 21, 18, 13, 1, the fetal fraction, and determine the gender of the fetus.
October 21 at 12:30 p.m. EDT: Accelerating precision oncology programs with genomically annotated and clinically characterized biospecimens
- Speaker: Shawn Levy, Ph.D., Genomics, Discovery Life Sciences, USA
What it’s about: Bridging a deep understanding of molecular profiles with clinical information is critical to developing innovative precision medicine tools in oncology. Discovery's recently launched SpecimenSeq product line makes this challenge easier for targeted oncology and liquid biopsy developers by delivering access to ethically collected biospecimen sets that are annotated with genomic and clinical characteristics.
3. Lightning talks
- Speaker: Preethi Gunaratne, Ph.D., Department of Biology & Biochemistry, University of Houston, USA
What it’s about: Unique sequences at the junctions of fusion proteins translated from chimeric RNAs form neoantigen peptide regions that expand the potential targets for therapeutic vaccines. This talk presents a platform that provides end-to-end service for discovering validated actionable fusions that can provide biomarkers for a selection of targeted therapies in a precision medicine format and reagents for developing tumor vaccines.
4. Happy hour trivia with a chance to win great prizes
October 21 at 7:00 p.m. EDT: Trivia Night: Are you a genetics genius?
What it’s about: Join us after a long virtual day of talks for a fun trivia night to test your knowledge of genetics facts. Best of all, dinner’s on us!
- Free GrubHub voucher for all trivia attendees*
- First place: Free pizza party (or taco party, or sushi party, or anything you want!) for your lab via GrubHub***
- Second place: Glow-in-the-dark shirt
- Third place: Stainless steel water bottle
5. On-demand co-labs
- Speaker: Sujash Chatterjee, Ph.D., QIAGEN
What it’s about: Learn about a new technique that allows ultra-plexing of thousands of samples per sequencing lane for accurate gene expression profiling from low-input and low-quality RNA samples. Once you’ve got your RNA-seq data, seamlessly move on to data analysis with the fully integrated, web-based RNA-seq Analysis Portal. Explore how you can go from sequence to gene expression insights in a day.
- Speakers: Jessica Sehr, Ph.D., QIAGEN and Jan-Niklas Schulz, Ph.D., QIAGEN
What it’s about: Find out what the latest nucleic acid extraction instrument can do for you. How fast can your team get trained on it? Can it process all your sample types? Is it true that it will let you do your lab work even from outside the lab? Is it really possible for your lab to acquire this instrument?
We look forward to ‘seeing’ you at this exciting virtual conference and exploring the world of human genetics together!